73
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Toxicity of superparamagnetic iron oxide nanoparticles on retinoblastoma mitochondria

, , &
Pages 69-74 | Received 12 Sep 2023, Accepted 20 Oct 2023, Published online: 31 Oct 2023
 

Abstract

Purpose

Retinoblastoma (RB) is one of the most important cancers in children with a higher rate of prevalence in developing countries. Despite different approaches to the treatment of RB, it seems necessary to discover a new approach to its treatment. Today, mitochondria are recognised as an important target in the treatment of cancer. Superparamagnetic iron oxide nanoparticles (SPIONs) have been studied by researchers due to their important biological effects.

Methods

In this study, the effects of SPIONs on mitochondria isolated from Y79 retinoblastoma cells were investigated.

Results

The results showed that SPIONs were able to increase the reactive oxygen species (ROS) level and subsequently damage the mitochondrial membrane and release cytochrome c a as one of the important pro-apoptotic proteins of RB mitochondria. Furthermore, the results indicated a decrease in cell viability and an increase in caspase-3 activity in Y79 retinoblastoma cells.

Conclusions

These events can lead to the killing of cancerous mitochondria. Our results suggest that SPIONs can cause mitochondrial dysfunction and death in RB mitochondria.

Author contributions

Jalal Pourahmad conceived, performed and designed and supervised the experiments and wrote the paper; Enayatollah Seydi and Ghazaleh Tahmasebi performed the experiments, wrote the paper and performed data analysis.

Disclosure statement

No potential conflict of interest was reported by the authors.

Data availability statement

The datasets used and analysed during the current study are available from the corresponding author upon reasonable request.

Additional information

Funding

This research was by supported by National Institute for Medical Research Development (NIMAD) in Tehran, Iran.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.